AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 38 filers reported holding AIM IMMUNOTECH INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $160,061 | -37.3% | 351,657 | -7.7% | 0.00% | – |
Q2 2023 | $255,206 | +55.8% | 380,905 | 0.0% | 0.00% | – |
Q1 2023 | $163,789 | +138704.2% | 380,905 | 0.0% | 0.00% | – |
Q4 2022 | $118 | -99.9% | 380,905 | -0.3% | 0.00% | – |
Q3 2022 | $222,000 | -25.3% | 382,014 | 0.0% | 0.00% | – |
Q2 2022 | $297,000 | -24.8% | 382,014 | +2.4% | 0.00% | – |
Q1 2022 | $395,000 | +15.2% | 372,953 | 0.0% | 0.00% | – |
Q4 2021 | $343,000 | -54.4% | 372,953 | 0.0% | 0.00% | – |
Q3 2021 | $753,000 | -0.4% | 372,953 | +6.0% | 0.00% | – |
Q2 2021 | $756,000 | -5.3% | 351,750 | 0.0% | 0.00% | – |
Q1 2021 | $798,000 | +90.0% | 351,750 | +49.7% | 0.00% | – |
Q4 2020 | $420,000 | -11.8% | 234,991 | +6.1% | 0.00% | – |
Q3 2020 | $476,000 | +24.3% | 221,489 | +43.1% | 0.00% | – |
Q2 2020 | $383,000 | – | 154,782 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |